191 related articles for article (PubMed ID: 21691438)
21. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
Abdullahi M; Adeniji SE; Arthur DE; Haruna A
J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
[TBL] [Abstract][Full Text] [Related]
22. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal activity of an imidazo[1, 2-a]pyridine using a mouse M. tuberculosis infection model.
Cheng Y; Moraski GC; Cramer J; Miller MJ; Schorey JS
PLoS One; 2014; 9(1):e87483. PubMed ID: 24498115
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
[TBL] [Abstract][Full Text] [Related]
26. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis and In Vitro Biological Evaluation of Pyridine, Thiadazole, Benzimidazole and Acetyl Thiophene Analogues as Anti Tubercular Agents Targeting Enzyme Inh A.
Suresh AJ; Nandini S; Sangeetha K; Dhivya LS; Surya PR
Curr Comput Aided Drug Des; 2021; 17(6):773-784. PubMed ID: 32713342
[TBL] [Abstract][Full Text] [Related]
28. Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis.
Fernandes GFS; Campos DL; Da Silva IC; Prates JLB; Pavan AR; Pavan FR; Dos Santos JL
ChemMedChem; 2021 Apr; 16(8):1268-1282. PubMed ID: 33410233
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antitubercular profile and molecular docking studies of quinazolinone-based pyridine derivatives against drug-resistant tuberculosis.
Raghu MS; Yogesh Kumar K; Shamala T; Alharti FA; Prashanth MK; Jeon BH
J Biomol Struct Dyn; 2024 Apr; 42(7):3307-3317. PubMed ID: 37261798
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
[TBL] [Abstract][Full Text] [Related]
31. Novel linear diamine disubstituted polycyclic 'cage' derivatives as potential antimycobacterial candidates.
Onajole OK; Sosibo S; Govender P; Govender T; van Helden PD; Maguire GE; Mlinarić-Majerski K; Wiid I; Kruger HG
Chem Biol Drug Des; 2011 Dec; 78(6):1022-30. PubMed ID: 21920029
[TBL] [Abstract][Full Text] [Related]
32. 3,5-dinitrobenzoylhydrazone derivatives as a scaffold for antituberculosis drug development.
Valverde TL; Sampiron EG; Montaholi DC; Baldin VP; Insaurralde DD; Alves-Olher VG; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Vandresen F; Scodro RB
Future Microbiol; 2022 Mar; 17():267-280. PubMed ID: 35164529
[No Abstract] [Full Text] [Related]
33. An
Tanner L; Haynes RK; Wiesner L
Front Pharmacol; 2019; 10():120. PubMed ID: 30833898
[TBL] [Abstract][Full Text] [Related]
34. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents.
Alsayed SSR; Lun S; Luna G; Beh CC; Payne AD; Foster N; Bishai WR; Gunosewoyo H
RSC Adv; 2020 Feb; 10(13):7523-7540. PubMed ID: 33014349
[TBL] [Abstract][Full Text] [Related]
36. Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity.
Kovalishyn V; Hodyna D; Sinenko VO; Blagodatny V; Semenyuta I; Slivchuk SR; Brovarets V; Poda G; Metelytsia L
Curr Drug Discov Technol; 2020; 17(3):365-375. PubMed ID: 30973110
[TBL] [Abstract][Full Text] [Related]
37. Recent developments of imidazo[1,2-
Samanta S; Kumar S; Aratikatla EK; Ghorpade SR; Singh V
RSC Med Chem; 2023 Apr; 14(4):644-657. PubMed ID: 37122538
[TBL] [Abstract][Full Text] [Related]
38. Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant
Hemeda LR; El Hassab MA; Abdelgawad MA; Khaleel EF; Abdel-Aziz MM; Binjubair FA; Al-Rashood ST; Eldehna WM; El-Ashrey MK
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2250575. PubMed ID: 37649381
[TBL] [Abstract][Full Text] [Related]
39. 2-Aryl benzazole derived new class of anti-tubercular compounds: Endowed to eradicate mycobacterium tuberculosis in replicating and non-replicating forms.
Velappan AB; Datta D; Ma R; Rana S; Ghosh KS; Hari N; Franzblau SG; Debnath J
Bioorg Chem; 2020 Oct; 103():104170. PubMed ID: 32890990
[TBL] [Abstract][Full Text] [Related]
40. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
